The Federal Trade Commission doubled down Wednesday on allegedly bogus health claims in ads on TV and elsewhere.
Not long after announcing a settlement with Nestle over claims for its Boost probiotic kids drink, the FTC announced that dietary supplement maker Iovate Health Sciences USA and a pair of affiliated Canadian companies will pay $5.5 million to settle charges it made bogus claims for a variety of products in TV ads, online pitches and print ads in magazines. Iovate has also agreed to stop making the claims unless it can back them up with evidence, including approval of the FDA for health claims and scientific evidence for weight loss.
Those claims, which appeared, among other places, on "various cable channels," included that Accelis, nanoSLIM, Cold MD, Germ MD and Allergy MD products could help users lose weight or prevent colds and other illnesses.
The FTC is particularly focused on such bogus health claims because of the potential, often immediate, harm deceptive claims can represent to consumers.